ATC Group: N05AX13 Paliperidone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N05AX13 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N05 Psycholeptics
3 N05A Antipsychotics
4 N05AX Other antipsychotics
5 N05AX13 Paliperidone

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 6 mg
PAREN - Parenteral (depot) 2.5 mg

Active ingredients in N05AX13

Active Ingredient Description
Paliperidone

Paliperidone is a selective blocking agent of monoamine effects, whose pharmacological properties are different from that of traditional neuroleptics. Even though paliperidone is a strong D2-antagonist, which is believed to relieve the positive symptoms of schizophrenia, it causes less catalepsy and decreases motor functions to a lesser extent than traditional neuroleptics.

Related product monographs

Title Information Source Document Type  
BYANNLI Prolonged-release suspension for injection European Medicines Agency (EU) MPI, EU: SmPC
INVEGA Prolonged-release tablet European Medicines Agency (EU) MPI, EU: SmPC
PALMEUX Prolonged-release suspension for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC
XEPLION Prolonged release suspension for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Singapore (SG)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.